Assignee
INFECTIOUS DISEASE RES INST
US·18 granted patents·17 pending applications·156 citations·filing 2007–2021
Top patents by PatentIndex Score
35 records- 0196US11141377B2Nanostructured lipid carriers and stable emulsions and uses thereofINFECTIOUS DISEASE RES INST·Filed 2018·Granted Oct 12, 2021·26 cites·24 claims
- 0296US9480740B2Synthetic glucopyranosyl lipid adjuvantsINFECTIOUS DISEASE RES INST·Filed 2014·Granted Nov 1, 2016·28 cites·10 claims
- 0396US8343512B2Treatment of allergic conditions using a composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2011·Granted Jan 1, 2013·30 cites·20 claims
- 0495US10632191B2Synthetic glucopyranosyl lipid adjuvantsINFECTIOUS DISEASE RES INST·Filed 2017·Granted Apr 28, 2020·6 cites·15 claims
- 0595US9950063B2Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2014·Granted Apr 24, 2018·16 cites·18 claims
- 0695US9907845B2Methods of using a vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2013·Granted Mar 6, 2018·17 cites·22 claims
- 0793US9987355B2Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2013·Granted Jun 5, 2018·13 cites·14 claims
- 0888US10792359B2Methods of using a vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2018·Granted Oct 6, 2020·1 cites·28 claims
- 0988US10765736B2Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2017·Granted Sep 8, 2020·1 cites·27 claims
- 1088US9814772B2Synthetic glucopyranosyl lipid adjuvantsINFECTIOUS DISEASE RES INST·Filed 2016·Granted Nov 14, 2017·5 cites·35 claims
- 1184US11266602B2PEGylated liposomes and methods of useINFECTIOUS DISEASE RES INST·Filed 2017·Granted Mar 8, 2022·2 cites·21 claims
- 1283US7833534B2Compounds and methods for diagnosis and treatment of leishmaniasisINFECTIOUS DISEASE RES INST·Filed 2007·Granted Nov 16, 2010·4 cites·17 claims
- 1374US9463198B2Compositions and methods for reducing or preventing metastasisINFECTIOUS DISEASE RES INST·Filed 2014·Granted Oct 11, 2016·6 cites·22 claims
- 1474US2021069324A1Methods of using a vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2020·Application pending·0 cites
- 1574US2021069323A1Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2020·Application pending·0 cites
- 1673US9822152B2Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and fusions thereofINFECTIOUS DISEASE RES INST·Filed 2013·Granted Nov 21, 2017·1 cites·27 claims
- 1769US11091521B2Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and fusions thereofINFECTIOUS DISEASE RES INST·Filed 2017·Granted Aug 17, 2021·0 cites·17 claims
- 1868US2009181078A1Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2009·Application pending·0 cites
- 1966US2018169226A1Vaccine Composition Containing Synthetic AdjuvantINFECTIOUS DISEASE RES INST·Filed 2018·Application pending·0 cites
- 2065US2021253650A1Compositions and methods for treating secondary tuberculosis and nontuberculous mycobacterium infectionsINFECTIOUS DISEASE RES INST·Filed 2021·Application pending·0 cites
- 2162US11173126B2Nanoalum particles comprising a PAA sizing agentINFECTIOUS DISEASE RES INST·Filed 2017·Granted Nov 16, 2021·0 cites·19 claims
- 2262US9279005B2Fusion proteins and their use in the diagnosis and treatment of leishmaniasisINFECTIOUS DISEASE RES INST·Filed 2014·Granted Mar 8, 2016·0 cites·10 claims
- 2359US2015072354A1Compounds and methods for diagnosis and treatment of leishmaniasisINFECTIOUS DISEASE RES INST·Filed 2014·Application pending·0 cites
- 2459US2016058860A1Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2015·Application pending·0 cites
- 2557US2011070290A1Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2010·Application pending·0 cites
- 2657US2011014274A1Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2010·Application pending·0 cites
- 2756US2022257747A1Methods and compositions of astrovirus repliconsINFECTIOUS DISEASE RES INST·Filed 2020·Application pending·0 cites
- 2855US9909114B2Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasisINFECTIOUS DISEASE RES INST·Filed 2014·Granted Mar 6, 2018·0 cites·23 claims
- 2954US2022396797A1Rig-i agonist and adjuvant formulation for tumor treatmentINFECTIOUS DISEASE RES INST·Filed 2020·Application pending·0 cites
- 3053US2016158329A1Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasisINFECTIOUS DISEASE RES INST·Filed 2014·Application pending·0 cites
- 3151US2015182612A1Compositions and methods for treating an active mycobacterium tuberculosis infectionINFECTIOUS DISEASE RES INST·Filed 2013·Application pending·0 cites
- 3251US2010317607A1Use of compounds for preparing anti-tuberculosis agentsINFECTIOUS DISEASE RES INST·Filed 2008·Application pending·0 cites
- 3350US2020148729A1Compositions and Methods for Treating Secondary Tuberculosis and Nontuberculosis Mycobacterium InfectionsINFECTIOUS DISEASE RES INST·Filed 2017·Application pending·0 cites
- 3447US2008107692A1Compositions and methods for the detection of trypanosoma cruzi infectionINFECTIOUS DISEASE RES INST·Filed 2007·Application pending·0 cites
- 3542US2020276299A1Liposomal formulations comprising saponin and methods of useINFECTIOUS DISEASE RES INST·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INFECTIOUS DISEASE RES INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →